INSP Inspire Medical Systems Inc

$72.39

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 10/2/2025

About Inspire Medical Systems Inc

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and Europe. The company is headquartered in Golden Valley, Minnesota.

Website: https://www.inspiresleep.com

Sector
LIFE SCIENCES
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
NYSE
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1609550
Address
5500 WAYZATA BLVD, SUITE 1600, GOLDEN VALLEY, MN, US
Valuation
Market Cap
$4.47B
P/E Ratio
85.35
PEG Ratio
nan
Price to Book
6.48
Performance
EPS
$1.76
Dividend Yield
—
Profit Margin
6.67%
ROE
8.48%
Technicals
50D MA
$168.18
200D MA
$180.98
52W High
$257.40
52W Low
$123.00
Fundamentals
Shares Outstanding
30M
Target Price
$226.07
Beta
1.39

INSP EPS Estimates vs Actual

● Estimated
● Actual

INSP News & Sentiment

Sep 15, 2025 • GlobeNewswire SOMEWHAT-BULLISH
Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc.
Mont-Saint-Guibert, Belgium - September 15, 2025, 10:10pm CET / 4:10pm ET - Nyxoah SA ( Euronext Brussels/Nasdaq: NYXH ) and Nyxoah, Inc. ( collectively, "Nyxoah" or the "Company" ) , a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea ( OSA ...
Sep 15, 2025 • Benzinga SOMEWHAT-BULLISH
Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc. - Nyxoah ( NASDAQ:NYXH )
Mont-Saint-Guibert, Belgium - September 15, 2025, 10:10pm CET / 4:10pm ET - Nyxoah SA ( Euronext Brussels/Nasdaq: NYXH ) and Nyxoah, Inc. ( collectively, "Nyxoah" or the "Company" ) , a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea ( OSA ...
Sep 08, 2025 • Benzinga NEUTRAL
INSPIRE INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigating Inspire Medical Systems, Inc. on Behalf of Inspire Stockholders and Encourages Investors to Contact the Firm - Inspire Medical Systems ( NYSE:INSP )
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Inspire ( INSP ) To Contact Him Directly To Discuss Their Options
Sep 03, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Why Is Inspire ( INSP ) Up 7.5% Since Last Earnings Report?
Inspire (INSP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Aug 27, 2025 • Benzinga NEUTRAL
Bragar Eagel & Squire, P.C. Is Investigating Agilon, Collective Mining, Fluor, and Inspire Medical and Encourages Investors to Contact the Firm - Collective Mining ( AMEX:CNL ) , Agilon Health ( NYSE:AGL )
NEW YORK, Aug. 27, 2025 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Agilon Health, Inc. AGL, Collective Mining Ltd. CNL, Fluor Corporation FLR, and Inspire Medical Systems, Inc.
Aug 26, 2025 • GlobeNewswire SOMEWHAT-BULLISH
Inspire Medical Systems, Inc. Announces Departure of Chief Financial Officer
MINNEAPOLIS, Aug. 26, 2025 ( GLOBE NEWSWIRE ) -- Inspire Medical Systems, Inc. ( NYSE: INSP ) ( Inspire ) , a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that ...
Sentiment Snapshot

Average Sentiment Score:

0.114
50 articles with scored sentiment

Overall Sentiment:

Neutral

INSP Reported Earnings

May 05, 2025
Mar 31, 2025 (Pre market)
0.0 Surprise
  • Reported EPS: $0.00
  • Estimate: $0.00
  • Whisper: —
  • Surprise %: 0.0%
Feb 04, 2025
Dec 31, 2024 (Pre market)
0.43 Surprise
  • Reported EPS: $1.15
  • Estimate: $0.72
  • Whisper: —
  • Surprise %: 59.0%
Nov 04, 2024
Sep 30, 2024 (Post market)
0.52 Surprise
  • Reported EPS: $0.60
  • Estimate: $0.08
  • Whisper: —
  • Surprise %: 650.0%
Aug 06, 2024
Jun 30, 2024 (Post market)
0.46 Surprise
  • Reported EPS: $0.32
  • Estimate: $-0.14
  • Whisper: —
  • Surprise %: 328.6%
May 07, 2024
Mar 31, 2024 (Post market)
0.31 Surprise
  • Reported EPS: $-0.34
  • Estimate: $-0.65
  • Whisper: —
  • Surprise %: 47.7%
Feb 06, 2024
Dec 31, 2023 (Post market)
0.58 Surprise
  • Reported EPS: $0.49
  • Estimate: $-0.09
  • Whisper: —
  • Surprise %: 644.4%
Nov 07, 2023
Sep 30, 2023 (Post market)
0.29 Surprise
  • Reported EPS: $-0.29
  • Estimate: $-0.58
  • Whisper: —
  • Surprise %: 50.0%
Aug 01, 2023
Jun 30, 2023 (Post market)
0.16 Surprise
  • Reported EPS: $-0.41
  • Estimate: $-0.57
  • Whisper: —
  • Surprise %: 28.1%
May 02, 2023
Mar 31, 2023 (Post market)
0.13 Surprise
  • Reported EPS: $-0.53
  • Estimate: $-0.66
  • Whisper: —
  • Surprise %: 19.7%

Financials